================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                         ------------------------------

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

       Date of report (Date of earliest event reported): September 8, 2006


                             ORION HEALTHCORP, INC.
             (Exact Name of Registrant as Specified in its Charter)


          Delaware                  001-16587                   58-1597246
(State or Other Jurisdiction       (Commission               (I.R.S. Employer
      of Incorporation)            File Number)           Identification Number)


                        1805 Old Alabama Road, Suite 350
                                Roswell, GA 30076
               (Address of Principal Executive Offices) (Zip Code)

                                 (678) 832-1800
              (Registrant's Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

     |_| Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)

     |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

     |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

     |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))

================================================================================



Section 1      Registrant's Business and Operations

Item 1.01      Entry into a Material Definitive Agreement

               On July 12, 2005, Orion HealthCorp, Inc. ("the Company") was
               named as a defendant in a suit entitled American International
               Industries, Inc. ("AII") vs. Orion HealthCorp, Inc. (previously
               known as SurgiCare, Inc.), Keith G. LeBlanc, Paul Cascio,
               Brantley Capital Corporation, Brantley Venture Partners III,
               L.P., Brantley Partners IV, L.P. (collectively, "the Named
               Defendants") and UHY Mann Frankfort Stein & Lipp CPAs, LLP ("UHY
               Mann") in the 80th Judicial District Court of Harris County,
               Texas, Cause No. 2005-44326. The case involved allegations that
               the Company made material and intentional misrepresentations
               regarding the financial condition of the parties to the
               acquisition and restructuring transactions effected on December
               15, 2004 for the purpose of inducing AII to convert its SurgiCare
               Class AA convertible preferred stock into shares of the Company's
               Class A Common Stock. AII asserted that the value of its Class A
               Common Stock of Orion had fallen as a direct result of the
               alleged material misrepresentations by the Company. AII was
               seeking an aggregate of $7,600,000 in damages (actual damages of
               $3,800,000 and punitive damages of $3,800,000), and rescission of
               the agreement to convert the SurgiCare Class AA convertible
               preferred stock into Class A Common Stock.

               On September 8, 2006, the Company entered into a Settlement
               Agreement with a Joint and Mutual Release and Indemnity Agreement
               (the "Settlement Agreement") in which the claims by AII against
               the Named Defendants were fully settled as to all claims, with
               complete mutual releases for all of the Named Defendants and AII.
               Under the terms of the Settlement Agreement, AII will receive
               $750,000, paid primarily by various insurance carriers of the
               Named Defendants, on or before 45 days from the execution of the
               Settlement Agreement. As part of the Settlement Agreement, the
               Named Defendants vigorously denied any liability and AII
               acknowledged the highly disputed nature of its claims against the
               Named Defendants. Both the Named Defendants and AII acknowledged
               that the Settlement Agreement was made as a compromise to avoid
               further expense and to terminate for all time the controversy
               underlying the lawsuit.

               A copy of the Settlement Agreement is attached as Exhibit 10.1 to
               this current report.

Item 7.01      Regulation FD Disclosure

               On September 14, 2006, the Company issued a press release that it
               had reached a settlement of the legal matter referenced in Item
               1.01 above. The press release is attached as Exhibit 99.1 to this
               current report.


Item 9.01.     Financial Statements and Exhibits.

(d) Exhibits - The following exhibits are furnished as part of this current
               report:

Exhibit        Description
10.1           Settlement Agreement with a Joint and Mutual Release and
               Indemnity Agreement, dated September 8, 2006, by and among
               American International Industries, Inc., International
               Diversified Corporation, Ltd. and Daniel Dror II as Claimants and
               Orion HealthCorp, Inc., Brantley Capital Corporation, Brantley
               Venture Partners III, L.P., Brantley Partners IV, L.P., Keith G.
               LeBlanc and Paul Cascio as Defendants
99.1           Copy of press release issued by the Company on September 14,
               2006.



                                   SIGNATURES
                                   ----------


     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                             ORION HEALTHCORP, INC.


                             By: /s/ Stephen H. Murdock
                                 ----------------------
                                 Stephen H. Murdock
                                 Chief Financial Officer



Date: September 14, 2006









                                  EXHIBIT INDEX

Exhibit
Number          Description of Exhibits
-------         -----------------------

10.1            Settlement Agreement with a Joint and Mutual Release and
                Indemnity Agreement, dated as of September 8, 2006, by and among
                American International Industries, Inc., International
                Diversified Corporation, Ltd. and Daniel Dror II as Claimants
                and Orion HealthCorp, Inc., Brantley Capital Corporation,
                Brantley Venture Partners III, L.P., BrantleyPartners IV, L.P.,
                Keith G. LeBlanc and Paul Cascio as Defendants

99.1            Copy of press release issued by the Company on September 14,
                2006.